About
Dr. Gregory Bailey is a Canadian physician-entrepreneur who co-founded and serves as Executive Chairman of Juvenescence Limited, a longevity-focused biotech company. He has a track record of founding and financing multiple companies across healthcare and technology, claiming to have generated over $28 billion in aggregate shareholder value across his portfolio. He is one of the most prominent and active investors specifically targeting the biology of aging.
Areas of interest
longevityaging biologybiotechAI drug discoveryregenerative medicinesenolyticsconsumer healthmetabolic scienceCNS/neuroscienceoncology